Kitoxan®
home > Kitoxan®
Kitoxan® by Latoxan
The first natural library of venom fractions for Drug Discovery and High Throughput Screening (HTS).
Kitoxan Kitoxan V01 Kitoxan V02 Kitoxan V03 Kitoxan V04
<< Back to Kitoxan V01

Search : `Naja nivea` - PubMed Results: 29
  1. The Toxin Diversity, Cytotoxicity, and Enzymatic Activity of Cape Cobra (Naja nivea) Venom.
    Lüddecke T, Avella I, Damm M, Schulte L, Eichberg J, Hardes K, Schiffmann S, Henke M, Timm T, Lochnit G, Vilcinskas A
    Toxins (Basel) 2024 Oct 11;16(10) PMID:39453214 PubMed - indexed for MEDLINE

  2. Proteomic Investigation of Cape Cobra (Naja nivea) Venom Reveals First Evidence of Quaternary Protein Structures.
    McFarlane LO, Pukala TL
    Toxins (Basel) 2024 Jan 23;16(2) PMID:38393141 PubMed - indexed for MEDLINE

  3. Snake Venomics and Antivenomics of Cape Cobra (Naja nivea) from South Africa: Insights into Venom Toxicity and Cross-Neutralization Activity.
    Tan CH, Wong KY, Huang LK, Tan KY, Tan NH, Wu WG
    Toxins (Basel) 2022 Dec 7;14(12) PMID:36548757 PubMed - indexed for MEDLINE

  4. Tako-tsubo cardiomyopathy in clinical toxinology: A systematic review.
    Pereañez JA, Granados J, Agudelo R
    Toxicon 2022 Nov;219:106929 PMID:36162498 PubMed - indexed for MEDLINE

  5. Distinctive Distribution of Secretory Phospholipases A? in the Venoms of Afro-Asian Cobras (Subgenus: Naja, Afronaja, Boulengerina and Uraeus).
    Tan CH, Wong KY, Tan NH, Ng TS, Tan KY
    Toxins (Basel) 2019 Feb 14;11(2) PMID:30769779 PubMed - indexed for MEDLINE

  6. Defining the pathogenic threat of envenoming by South African shield-nosed and coral snakes (genus Aspidelaps), and revealing the likely efficacy of available antivenom.
    Whiteley G, Casewell NR, Pla D, Quesada-Bernat S, Logan RAE, Bolton FMS, Wagstaff SC, Gutiérrez JM, Calvete JJ, Harrison RA
    J Proteomics 2019 Apr 30;198:186-198 PMID:30290233 PubMed - indexed for MEDLINE

  7. An efficient analytical platform for on-line microfluidic profiling of neuroactive snake venoms towards nicotinic receptor affinity.
    Heus F, Vonk F, Otvos RA, Bruyneel B, Smit AB, Lingeman H, Richardson M, Niessen WM, Kool J
    Toxicon 2013 Jan;61:112-24 PMID:23159399 PubMed - indexed for MEDLINE

  8. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS, Wanas S, Helmy MH, Hashem M
    J Nat Toxins 2002 Dec;11(4):329-35 PMID:12503876 PubMed - indexed for MEDLINE

  9. Poul Agerholm Christensen MD (1912-1991): antivenom production at the South African Institute for Medical Research.
    Hawgood BJ
    Toxicon 2001 Jun;39(6):749-56 PMID:11137532 PubMed - indexed for MEDLINE

  10. A three-compartment open pharmacokinetic model can explain variable toxicities of cobra venoms and their alpha toxins.
    Ismail M, Aly MH, Abd-Elsalam MA, Morad AM
    Toxicon 1996 Sep;34(9):1011-26 PMID:8896193 PubMed - indexed for MEDLINE

  11. Far-u.v. CD-spectroscopy and immunological properties of synthetic sequential peptides derived from cardiotoxin VII1 of Naja nivea venom: an amphipathic alpha-helix formed by sequence 15-25 of a beta-protein.
    Osthoff G
    Int J Biochem 1989;21(12):1365-8 PMID:2482207 PubMed - indexed for MEDLINE

  12. Clinical manifestations of Cape cobra (Naja nivea) bites. A report of 2 cases.
    Blaylock RS, Lichtman AR, Potgieter PD
    S Afr Med J 1985 Aug 31;68(5):342-4 PMID:4035501 PubMed - indexed for MEDLINE

  13. In vivo effects of snake venoms on passive and facilitated glucose transport across blood-ocular and blood-CSF barriers of the rat.
    DiMattio J, Weinstein S, Streitman J
    Toxicon 1985;23(1):63-71 PMID:3992599 PubMed - indexed for MEDLINE

  14. Preparation and characterization of monoclonal antibody specific for Naja nivea cardiotoxin VII1.
    Kfir R, Botes DP, Osthoff G
    Toxicon 1985;23(1):135-44 PMID:3992596 PubMed - indexed for MEDLINE

  15. Proteolytic activities of cobra venoms based on inactivation of alpha 2-macroglobulin.
    Evans HJ, Guthrie VH
    Biochim Biophys Acta 1984 Jan 31;784(2-3):97-101 PMID:6197999 PubMed - indexed for MEDLINE

  16. Protease inhibitor homologues from mamba venoms: facilitation of acetylcholine release and interactions with prejunctional blocking toxins.
    Harvey AL, Karlsson E
    Br J Pharmacol 1982 Sep;77(1):153-61 PMID:6751453 PubMed - indexed for MEDLINE

  17. Snake venoms. The amino acid sequences of two Melanoleuca-type toxins.
    Joubert FJ, Taljaard N
    Hoppe Seylers Z Physiol Chem 1980;361(3):425-36 PMID:7380387 PubMed - indexed for MEDLINE

  18. Purification of monospecific antisera against the venom of the cape cobra (Naja nivea).
    Madsen T, Lundström H, Fohlman J
    Toxicon 1979;17(3):326-30 PMID:473250 PubMed - indexed for MEDLINE

  19. Purification, some properties and the primary structures of three reduced and S-carboxymethylated toxins (CM-5, CM-6 and CM-10a) from Naje haje haje (Egyptian cobra) venom.
    Joubert F, Taljaard N
    Biochim Biophys Acta 1978 Nov 20;537(1):1-8 PMID:718974 PubMed - indexed for MEDLINE

  20. Discrimination between nicotinic receptors in vertebrate ganglia and skeletal muscle by alpha-bungarotoxin and cobra venoms.
    Bursztajn S, Gershon MD
    J Physiol 1977 Jul;269(1):17-31 PMID:894538 PubMed - indexed for MEDLINE

  21. The amino acid sequence of three non-curarimimetictoxins from Naja nivea venom.
    Botes DP, Viljoen CC
    Biochim Biophys Acta 1976 Sep 28;446(1):1-9 PMID:823968 PubMed - indexed for MEDLINE

  22. Snake venom proteinase inhibitors. III. Isolation of five polypeptide inhibitors from the venoms of Hemachatus haemachatus (Ringhal's corbra) and Naja nivea (Cape cobra) and the complete amino acid sequences of two of them.
    Hokama Y, Iwanaga S, Tatsuki T, Suzuki T
    J Biochem 1976 Mar;79(3):559-78 PMID:950337 PubMed - indexed for MEDLINE

  23. Amino-acid sequence of toxin III of Naja haje.
    Kopeyan C, Miranda F, Rochat H
    Eur J Biochem 1975 Oct 1;58(1):117-22 PMID:1183429 PubMed - indexed for MEDLINE

  24. Snake venom toxins. The reactivity of the disulphide bonds of Naja nivea toxin alpha.
    Botes DP
    Biochim Biophys Acta 1974 Aug 8;359(2):242-7 PMID:4212340 PubMed - indexed for MEDLINE

  25. Effects of Naja nivea venom on nerve, cardiac and skeletal muscle activity of the frog.
    Loots JM, Meij HS, Meyer BJ
    Br J Pharmacol 1973 Mar;47(3):576-85 PMID:4354326 PubMed - indexed for MEDLINE

  26. The effects of toxic components of Naja nivea (Cape cobra) venom on neuromuscular transmission and muscle membrane permeability.
    Earl JE, Excell BJ
    Comp Biochem Physiol A Comp Physiol 1972 Mar;41(3):597-615 PMID:4401732 PubMed - indexed for MEDLINE

  27. Snake venom toxins. The amino acid sequences of toxins and from Naja nivea venom and the disulfide bonds of toxin .
    Botes DP
    J Biol Chem 1971 Dec 10;246(23):7383-91 PMID:5167022 PubMed - indexed for MEDLINE

  28. Snake venom toxins. Purification and properties of three toxins from Naja nivea (Linnaeus) (Cape cobra) venom and the amino acid sequence of toxin delta.
    Botes DP, Strydom DJ, Anderson CG, Christensen PA
    J Biol Chem 1971 May 25;246(10):3132-9 PMID:4995745 PubMed - indexed for MEDLINE

  29. The action of a depolarizing fraction from Naja nivea venom on frog skeletal muscle.
    Earl JE, Excell BJ
    J Physiol 1971;214 Suppl:27P-28P PMID:5575362 PubMed - indexed for MEDLINE
For Research Purposes Only - Not for Human Use

Privacy Statement | Ordering Informations | www.latoxan.com | www.biotoxan.com
Natural Active Ingredients - Venoms - Toxins - Alkaloids - Plant Compounds - Ion Channel & Receptor Ligands
LATOXAN SAS - Z.A. les Auréats, 845 Avenue Pierre Brossolette - 26800 PORTES-lès-VALENCE - France - Phone +33 475 419 191 - Fax +33 475 419 199 - www.latoxan.com
Optimised for Mozilla FireFox & Google Chrome (not for IE) - Copyright © Latoxan 2010
Last update : 2024-12-22 04:10:50